Z13.220 is a 2026 ICD-10-CM code for a clinical encounter where an asymptomatic patient is screened for lipoid disorders, including various forms of hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia. Screening for lipoid disorders is a foundational component of preventative cardiovascular medicine, aimed at identifying dyslipidemias that contribute to the development of atherosclerotic cardiovascular disease (ASCVD). The encounter typically involves a comprehensive review of the patient's cardiovascular risk factors and the performance of a lipid panel, which measures total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides. Early detection allows for the implementation of therapeutic lifestyle changes, such as the Mediterranean or DASH diets and increased aerobic exercise, or the initiation of lipid-lowering pharmacotherapy (e.g., statins, ezetimibe, PCSK9 inhibitors, or bempedoic acid). This code is used when no current symptoms or established diagnosis of a lipoid disorder are present at the time of the encounter.
Distinguish between screening and diagnostic intent to ensure correct application of Z13.220.
Example: Asymptomatic 45-year-old male presents for routine cardiovascular risk assessment. No history of xanthomas or premature CAD. Ordered lipid panel to screen for hyperlipidemia. Billing Focus: Screening status for asymptomatic patient. Risk Adjustment: Correctly identifying as a preventive encounter rather than chronic disease management.
Billing Focus: Identify the encounter as preventive/screening in nature rather than diagnostic for existing symptoms.
Incorporate family history codes when screening is prompted by genetic risk factors.
Example: Patient requests lipid screening due to a strong family history of familial hypercholesterolemia in a first-degree relative. Documentation notes absence of current lipid-lowering therapy. Billing Focus: Secondary code Z83.42 used to support medical necessity for screening. Risk Adjustment: Highlights potential genetic predisposition affecting future risk tiers.
Billing Focus: Use of secondary family history codes to support medical necessity for early or frequent screening.
Document the absence of existing signs or symptoms of lipoid disorders.
Example: Physical exam reveals no evidence of arcus senilis or tendon xanthomata. Patient denies chest pain or claudication. Screening lipid panel ordered per age-based guidelines. Billing Focus: Clinical documentation of the absence of symptoms justifies the Z13.220 screening code. Risk Adjustment: Confirms the patient is currently in a wellness or early detection phase.
Billing Focus: Negative physical exam findings relative to hyperlipidemia signs.
Transition from screening to diagnostic coding if a disorder is identified during the encounter.
Example: Initial screening encounter for lipoid disorder. Lab results from the same day confirm LDL of 190 mg/dL. Final assessment updated to E78.01 (Pure hypercholesterolemia, familial). Billing Focus: Transition from Z-code to E-code once diagnosis is confirmed. Risk Adjustment: E78.01 may influence risk adjustment depending on the specific model used.
Billing Focus: Sequence the definitive diagnosis code first if results are available and abnormal.
Specify the clinical guideline followed for the screening encounter.
Example: Encounter for lipid screening following USPSTF Grade B recommendations for adults aged 40 to 75 years. Patient is currently non-smoker with BP 120/80. Billing Focus: Documentation of guideline adherence supports the use of screening codes for payers. Risk Adjustment: Demonstrates proactive management of cardiovascular risk factors.
Billing Focus: Reference to standard screening guidelines (e.g., USPSTF, AHA/ACC).
This is the primary laboratory test performed during a screening for lipoid disorders.
Used when only a total cholesterol screening is performed rather than a full panel.
Component of the screening process to evaluate protective cholesterol levels.
Screening for hyperglyceridemia as part of lipoid disorder detection.
Used for very brief encounters where only a screening order is discussed.
Appropriate for screening discussions involving minor risk factor review.
The standard CPT for a wellness visit where Z13.220 screening is ordered.
The most common age range for routine lipoid disorder screening.
The procedure code for drawing the blood required for the lipid screening.
Used if the provider spends dedicated time discussing cardiovascular risk factors and lipid screening benefits.